Table 1. Medications evaluated for the medical management of painful achalasia.
Drug class | Mechanism of action in achalasia | Common adverse effects 30 |
---|---|---|
Calcium channel blockers3 | Reduce intracellular uptake of calcium, hence decreasing muscle contractility, which relaxes the LOS | Headache, dizziness, flushing, peripheral oedema, nausea & vomiting, abdominal pain |
Nitrates3 | Cause the release of nitrous oxide, resulting in relaxation of the LOS | Headache, dizziness, flushing, drowsiness, nausea & vomiting, hypotension |
Sildenafil21 | Inhibits phosphodiesterase type 5, hence increasing cyclic monophosphate levels, which have an inhibitory effect on smooth muscle cells | Headache, dizziness, fluid retention, gastrointestinal symptoms including diarrhea, nausea, night sweats, anxiety, insomnia, cough |
Terbutaline19 | Stimulates beta2-receptors in smooth muscle cells which causes relaxation of the smooth muscle | Headache, nausea, arrythmias, palpitations, tremor, hypotension, hypokalaemia, muscle spasms |
LOS, lower esophageal sphincter.